T2Bacteria Impact on Diagnostics & Clinical Outcomes in Sepsis and Bloodstream Infections

White Paper

The T2Bacteria® Panel provides species-specific results, directly from whole blood within 3 to 5 hours of first blood draw, often before the second dose of empiric antibiotics are given. This enables clinicians to target therapy for patients suspected of sepsis, when every hour counts.

To read a summary of clinical literature evaluating the performance and clinical outcomes of the T2Bacteria Panel for the diagnosis of bloodstream infections, download our latest white paper.

Please enter your email address for instant access to the white paper.